Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

AUD

Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple…
Filament Health (FH.NE) announced today that it has received approval from Health Canada for a Phase 2 clinical trial using PEX010, the Company’s botanical psilocybin drug candidate. Cybin Therapeutics…
Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. “AUD is a chronic relapsing brain…